CIK 0001087294
- Non-accelerated filer
- Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- Operating
- EIN
- 621765329
- Phone
- +1 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Gift Chairman and CEO gave 60,000 shares (gift)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 1,950 shares (grant or award)
- 4 Grant or award SVP and Chief Development Off. acquired 6,500 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 5,775 shares (grant or award)
- 4 Open-market sale Director sold 4,000 shares at $5.61 ($22,440)
- 4 Open-market sale Director sold 6,000 shares at $6.88 ($41,280)
- 4 Option exercise Director acquired 700 shares (option exercise)
- 4 Grant or award SVP and Chief Development Off. acquired 5,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award VP and Chief Compliance Office acquired 4,000 shares (grant or award)
- 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 11,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Open-market sale Director sold 6,000 shares at $6.95 ($41,700)
- 4 Open-market sale Director sold 10,000 shares at $5.12 ($51,200)
- 4 Open-market sale Director sold 15,000 shares at $5.08 ($76,200)
Page 20 of 26 · 512 filings